Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shaimil Laboratories is an integrated pharmaceutical manufacturing and exporting company based in Vadodara, Gujarat, India. Established in 1986, the company operates a WHO-GMP-certified facility specializing in oral solid dosage forms, including tablets and capsules, as well as other formulations such as injections, soft gelatin capsules, topicals, and oral liquids. Shaimil Laboratories produces a wide range of generic medications across therapeutic areas like cardiovascular, respiratory, gastroenterology, and ophthalmology, alongside biosimilar products such as heparin and insulin. The company serves both domestic and international markets, exporting its products to Europe, Latin America, Africa, and South Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shaimil Laboratories.